IPOs News

  • Men's Grooming Company Manscaped In Talks To Go Public Via SPAC: What Investors Should Know
    IPOs - 6 hours ago
    A company that specializes in men’s grooming products is in talks to go public via SPAC. Here are the details on the potential merger of Manscaped and what investors should know about the company. What Happened: Manscaped, a company that focuses on “below the waist hygiene” is in talks to go public with the SPAC…
  • Immuneering Announces Pricing of Upsized Initial Public Offering
    IPOs - 18 hours ago
    CAMBRIDGE, Mass., July 29, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (NASDAQ:IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced the pricing of its upsized initial public offering of 7,500,000 shares of Class A common stock at a public offering…
  • RxSight, Inc. Announces Pricing of Initial Public Offering
    IPOs - 19 hours ago
    ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) — RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial public offering of 7,350,000 shares of common stock at a public offering price of $16.00 per share. The gross proceeds to RxSight® from the offering are expected to be $117.6 million, before…
  • Williams Rowland Acquisition Corp. Announces Closing of $200 Million Initial Public Offering
    IPOs - 20 hours ago
    Westport, CT, July 29, 2021 (GLOBE NEWSWIRE) — Williams Rowland Acquisition Corp. (the “Company”), a newly organized blank check company incorporated as a Delaware corporation and led by Co-Chief Executive Officers, David “Tiger” Williams and Jonathan Rowland, today announced the closing of its initial public offering of 20,000,000 units at an offering price of $10.00…
  • IN8bio Announces Pricing of Initial Public Offering
    IPOs - 10 hours ago
    NEW YORK, July 30, 2021 (GLOBE NEWSWIRE) — IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies utilizing its DeltEx platform (“IN8bio” or the “Company”), today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering…
  • London-Listed MaxCyte Makes NASDAQ Debut Today
    IPOs - 4 hours ago
    MaxCyte Inc (NASDAQ: MXCT) is already trading on London’s AIM, but now, it debuted on NASDAQ after pricing a $176 million IPO at $13 apiece, on the higher end of an $11.50 to $13.50 …Full story available on Benzinga.com
  • XPO Logistics Spinoff GXO Logistics To Ring NYSE Opening Bell On Monday
    IPOs - 2 hours ago
    XPO Logistics Inc's (NYSE: XPO) logistics segment spin-off, GXO Logistics (NYSE: GXO), is slated for debut on August 2, 2021. The executive team and members of the board of directors of GXO Logistics, Inc. will ring the …Full story available on Benzinga.com
  • Rani Therapeutics Announces Pricing of Initial Public Offering
    IPOs - 8 hours ago
    SAN JOSE, Calif., July 30, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”), a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics, today announced the pricing of its initial public offering of 6,666,667 shares of Class A common stock at a price to…
  • Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The Biopharma
    IPOs - 1 hour ago
    Rani Therapeutics Holdings, Inc. (NASDAQ: RANI), a San Jose, California-based early stage biopharma, debuted Friday on the Nasdaq in its initial public offering. Rani Shares Trade Around IPO Price: Rani shares opened for trading at $11.26, above the IPO price of $11. Since then, the stock has traded in a $10.50-$12.17 range. The company offered 6.67…
  • Alpha Healthcare Acquisition Corp. III Announces Closing of $150 Million Initial Public Offering
    IPOs - 1 day ago
    New York, NY, July 29, 2021 (GLOBE NEWSWIRE) — Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPAU) (the “Company”) announced today that it closed its initial public offering of 15,000,000 units at a price of $10.00 per unit.   The Company's units are listed on the Nasdaq Capital Market and commenced trading under the ticker symbol “ALPAU” on…
  • The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
    IPOs - 9 hours ago
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV) Absci, CORP (NASDAQ: ABSI) (IPOed July 22) Alkermes plc (NASDAQ: ALKS) Arvinas, Inc. (NASDAQ: ARVN) Axonics, Inc. (NASDAQ: AXNX) Bio-Rad Laboratories, Inc. (NYSE: BIO) Biohaven Pharmaceutical…
  • Southern States Bancshares Announces Launch of Initial Public Offering
    IPOs - 8 hours ago
    ANNISTON, Ala., July 30, 2021 (GLOBE NEWSWIRE) — Southern States Bancshares, Inc. (“Southern States”), the holding company for Southern States Bank, an Alabama state-charted commercial bank (the “Bank”), announced today that it has commenced an initial public offering of 996,429 shares of common stock to be offered by Southern States and 1,003,571 shares of common…
  • Omega Therapeutics Kicks Start Trading On NASDAQ
    IPOs - 4 hours ago
    On the heels of a $126 million crossover round in March, Flagship Pioneering-backed Omega Therapeutics Inc (NASDAQ: OMGA) has priced a $125.8 million IPO to take its "epigenomic controllers" into the clinic. Omega had initially penciled in a $100 million raise earlier this month. It offered 7.4 million shares …Full story available on Benzinga.com
  • Oncology-Focused Biotech Immuneering Jumps To Wall Street With $112M IPO
    IPOs - 3 hours ago
    Immuneering Corp (NASDAQ: IMRX) has kept a relatively low profile since launching with $17 million back in 2019. That is until it landed another $62 million and recruited Jefferies analyst Biren Amin as CFO earlier this year.  Now, the biotech is hopping onto NASDAQ with a …Full story available on Benzinga.com
  • Here's Why You Can't Sell Your Robinhood IPO Shares On The Platform Yet
    IPOs - 2 hours ago
    Robinhood launched limited IPO trading earlier this year where it would offer allocations of select public offerings to investors. Included in this was shares of the company’s own stock. Rules put in place to prevent users from day trading IPOs are providing a lesson to investors. What Happened: The highly anticipated IPO of Robinhood Markets…